Dan Levine
Reuters Top News
Contact Dan
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Dan:
Corporate lawsuit dodge imperiled after court rejects J&J bankruptcy tactic
Attorney Greg Gordon, a partner at the Jones Day law firm, offered an innovative solution to Johnson & Johnson and other major companies that faced mountains of lawsuits alleging their products sickened or killed people: They could use the bankruptcy system to force all plaintiffs into one settlement. → Read More
U.S. court rejects J&J bankruptcy strategy for tens of thousands of talc lawsuits
A U.S. appeals court upended Johnson & Johnson's attempt to offload into bankruptcy tens of thousands of lawsuits over its talc products, ruling the healthcare conglomerate improperly placed a subsidiary into Chapter 11 proceedings even though it did not face financial distress. → Read More
Special Report: Boy Scouts, Catholic dioceses find haven from sex abuse suits in bankruptcy
Lawmakers around the United States have tried to grant justice to victims of decades-old incidents of child sexual abuse by giving them extra time to file lawsuits. Those defendants, including church and youth groups, are counterpunching in bankruptcy courts. → Read More
Elizabeth Holmes arrives in court to face sentencing for Theranos fraud
Theranos founder Elizabeth Holmes arrived on Friday at a federal courthouse in San Jose, Calif., where she is scheduled to be sentenced for defrauding investors in her now-defunct blood testing startup. → Read More
How corporate chiefs dodge lawsuits over sex abuse and deadly products
Wealthy company leaders regularly escape accountability for corporate scandals by demanding lifetime protection from related lawsuits in bankruptcy court. → Read More
Exclusive: Tesla faces U.S. criminal probe over self-driving claims
The U.S. Department of Justice launched the probe last year following more than a dozen crashes, some fatal, involving Tesla’s driver assistance system Autopilot, people familiar with the matter say. → Read More
Exclusive: U.S. finds new quality problems at Lilly drug factory
U.S. drug inspectors recently recorded several new quality- control problems at an Eli Lilly and Co plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters. → Read More
Justice Kagan warns U.S. Supreme Court must maintain public confidence
Liberal Justice Elena Kagan said on Thursday that it would be a "dangerous thing for a democracy" if the conservative-majority U.S. Supreme Court loses the confidence of the American public. → Read More
How a bankruptcy ‘innovation’ halted thousands of lawsuits from sick p
Four major companies have used the 'Texas two-step' to dodge thousands of cases brought by sick plaintiffs, forcing them to seek settlements in bankruptcy court. Now, a whistleblower is providing insight into the secretive process. → Read More
FDA requires disclosure of suicide risk for anti-baldness drug
U.S. health regulators rejected a request to remove popular anti-baldness pill Propecia and its generic versions from the market, but for the first time required patient notification about reports of suicidal behavior in men taking the drug. → Read More
Whistleblower sues Eli Lilly over drug manufacturing problems
A former human resources officer at Eli Lilly & Co sued the pharmaceutical company on Monday, alleging she was terminated after pointing out poor manufacturing practices and data falsification involving its blockbuster diabetes drug. → Read More
Congressional Democrats target U.S. judiciary over recusal, secrecy
Democrats in the U.S. Congress proposed a raft of new rules for the federal judiciary on Wednesday including a formal mechanism to remove judges from hearing cases in the event of a conflict of interest and another intended to reduce secret court filings. → Read More
Special Report: Inside J&J’s secret plan to cap litigation payouts to cancer victims
Johnson & Johnson created a plan last year to limit the financial bleeding from billions of dollars in jury awards to plaintiffs who alleged the company’s Baby Powder and other talc products caused deadly cancers. The healthcare and consumer-goods giant assigned more than 30 staffers to “Project Plato.” In a memo on the project in July, a company lawyer warned the team: Tell no one, not even… → Read More
Analysis: Purdue Pharma ruling targets controversial U.S. bankruptcy tactic
A federal judge's decision to unravel a settlement shielding members of the Sackler family from future opioid litigation could upend a controversial corner of U.S. bankruptcy law: protecting third parties who have not filed for Chapter 11 themselves. → Read More
Exclusive: Eli Lilly’s recalled emergency diabetes drug came from plant cited by FDA
A recently recalled batch of Glucagon Emergency Kits, Eli Lilly and Co’s therapy for diabetic patients in crisis, was manufactured at an Indiana factory cited by U.S. health regulators this year for quality-control violations, including several involving that product, according to the company and a Reuters review of federal inspection records. → Read More
U.S. decision on Pfizer COVID-19 shot for kids age 5-11 could come in October -sources
Top U.S. health officials believe that Pfizer Inc's COVID-19 vaccine could be authorized for children aged 5-11 years old by the end of October, two sources familiar with the situation said on Friday. → Read More
EXCLUSIVE J&J exploring putting talc liabilities into bankruptcy-sources
Johnson & Johnson (JNJ.N) is exploring a plan to offload liabilities from widespread Baby Powder litigation into a newly created business that would then seek bankruptcy protection, according to seven people familiar with the matter. → Read More
Eli Lilly resolves lobbyist's sex discrimination lawsuit
Eli Lilly & Co has resolved a lawsuit filed in March by a former top lobbyist who accused a high-ranking executive and another senior manager of engaging in sexual discrimination, harassment and retaliation against women in its Washington, D.C., office, according to a court filing on Monday. → Read More
EXCLUSIVE Eli Lilly memo says firm did not make false statements to FDA
A week before Eli Lilly (LLY.N) disclosed to regulators that the U.S. Justice Department was investigating its New Jersey factory, the drugmaker told employees that its own inquiry, led by an outside law firm, found no evidence of wrongdoing there, according to a company memo reviewed by Reuters. → Read More
Exclusive-U.S. opens criminal probe into alleged lapses at Eli Lilly plant
The U.S. Justice Department has launched a criminal investigation into Eli Lilly and Co focused on alleged manufacturing irregularities and records tampering at a factory in Branchburg, New Jersey, that produces the pharmaceutical giant's COVID-19 therapy and other drugs... → Read More